Tekmira Sues Partner Alnylam for Misuse of Trade Secrets

Tekmira alleges that Alnylam has, among other things, illegally used its proprietary technology to develop new versions of lipid nanoparticle delivery agents.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.